z-logo
open-access-imgOpen Access
CD133, but Not CD44, May Serve as a Novel Biomarker for Differential Diagnosis Between Basal Cell Carcinoma and Trichoblastomas
Author(s) -
Yalan Bi,
Xiaohua Shi,
Dian Chen,
Yi Zhao
Publication year - 2022
Publication title -
clinical, cosmetic and investigational dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.73
H-Index - 35
ISSN - 1178-7015
DOI - 10.2147/ccid.s373331
Subject(s) - receiver operating characteristic , biomarker , cd44 , medicine , area under the curve , immunostaining , gastroenterology , pathology , basal cell carcinoma , basal (medicine) , immunohistochemistry , basal cell , cell , biology , biochemistry , genetics , insulin

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here